Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.8M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$131M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Martin Samuel Bates | Jun 14, 2024 | Sell | 17,172 | $35.4248 | $610,000 |
| Crowley Elizabeth | Jun 14, 2024 | Sell | 30,000 | $34.8654 | $1M |
| Crowley Elizabeth | Jun 7, 2024 | Sell | 15,000 | $35.0582 | $530,000 |
| Young Diane C. | Jun 7, 2024 | Sell | 45,000 | $35.2632 | $1.6M |
| Heath-Chiozzi Margo | Jun 3, 2024 | Sell | 58,369 | $33.6495 | $2M |
| Wright Richard M. | Jun 3, 2024 | Sell | 27,580 | $33.5264 | $920,000 |
| Wright Richard M. | Jun 3, 2024 | Sell | 19,264 | $33.9854 | $650,000 |
| Jimenez Freddy A. | Jun 3, 2024 | Sell | 8,006 | $33.6001 | $270,000 |
| Heath-Chiozzi Margo | May 30, 2024 | Sell | 38,719 | $34.07 | $1.3M |
| Martin Samuel Bates | May 30, 2024 | Sell | 35,000 | $34.0507 | $1.2M |
| Cavanaugh Sarah | May 30, 2024 | Sell | 20,853 | $33.7282 | $700,000 |
| Crowley Elizabeth | May 30, 2024 | Sell | 38,597 | $33.6395 | $1.3M |
| KELER TIBOR | Dec 7, 2022 | Sell | 16,860 | $36.9283 | $620,000 |
What's the latest insider transaction for Celldex Therapeutics?
The most recent insider transaction for Celldex Therapeutics was conducted by Martin Samuel Bates, who sold 17,172 shares on June 14, 2024 at a price of $35.42 per share.
Which insider has sold the most CLDX stock over the last two years?
Heath-Chiozzi Margo has sold the most CLDX stock in the last 2 years, with a total value of $3.3M.
What is the total value of insider transactions for Celldex Therapeutics (CLDX) in the last 2 years?
The total value of insider transactions for Celldex Therapeutics in the last 2 years is negative, amounting to -$13M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Celldex Therapeutics' market confidence?
Over the last 2 years, insider transactions for Celldex Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
